Avail Bio
San Francisco, United States · Founded 2018
- Headquarters
- San Francisco, California
- Founded
- 2018
- Business Model
- B2B
- Website
- avail.bio
- Last Round
- SeedOct 2018
- Rounds
- 1
About
Avail Bio is a venture-backed genomic biotechnology company advancing synthetic immunology for cancer treatment. The company couples mammalian synthetic biology with informatics to engineer immune cells with improved therapeutic properties. Avail Bio focuses on immunotherapy applications, particularly in oncology, developing companion diagnostics and next-generation cell therapy platforms. The company was part of the BIO Investor Forum and has been cited in peer-reviewed cancer immunotherapy research.
Summary
Avail Bio is a Biotech company based in San Francisco, United States, founded in 2018. Its most recent funding was a Seed round in Oct 2018. Investors include Fifty Years and First In.
Funding History
Oct 2018
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/avail-bio"><img src="https://indexed.vc/api/badge/company/avail-bio" alt="Avail Bio on Indexed.vc" width="260" height="76" /></a>